Avricore Health Inc V.AVCR

Q1

[lscfa]

No bloody explanation why revenues are down when devices deployed is up.

 

	Devices
Qtr ending	Deployed	Revenue	Gross Profit	Margin	Cash expenses	Cfo
Q1 23	532	629,241	210,681	33.5%	235,940	(25,259)
Q4 22	416	977,235	168,845	17.3%	83,937	84,908
Q3 22	166	572,228	215,961	37.7%	262,632	(46,671)
Q2 22	53	176,175	56,874	32.3%	233,103	(176,229)
Q1 22	53	42,736	15,113	35.4%	172,113	(157,000)
Q4 21	20	35,190	9,317	26.5%

[M1bmx115]

They make money from selling tests for the devices.  They've said in the past that their sales of tests are somewhat unpredictable.  I assume that's why revenue is down qoq.  Management has given us no reason so we're left to speculate. Management deserves a kick in the groin for the way they've handled this.  The stock was down 40% at one point after the

[HobbyDigger2]

additionally the Options granted @20 only.